ACUTE HEMOLYTIC TRANSFUSION REACTION, A PARADIGM OF THE SYSTEMIC INFLAMMATORY RESPONSE - NEW INSIGHTS INTO PATHOPHYSIOLOGY AND TREATMENT

Dinarello CA, Gelfand JA, Wolff SM., Anticytokine strategies in the treatment of the systemic inflammatory response syndrome, JAMA, 269, pp. 1829-1835, (1993)

Tracey KJ, Fong Y., Hesse DG, Et al., Anti‐cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia, Nature, 330, pp. 662-664, (1987)

Van Zee KJ, Kohno T., Fischer E., Et al., Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor‐a in vitro and in vivo, Proc Natl Acad Sci USA, 89, pp. 4845-4849, (1992)

Arend WP., Interleukin 1 receptor antagonist. A new member of the interleukin 1 family, J Clin Invest, 88, pp. 1445-1451, (1991)

Gershenwald JE, Fong YM, Fahey TJ, Et al., Interleukin 1 receptor blockage attenuates the host inflammatory response, Proc Natl Acad Sci U S A, 87, pp. 4966-4970, (1990)

Fanslow WC, Sims JE, Sassenfeld H., Et al., Regulation of alloreactivity in vivo by a soluble form of the interleukin‐1 receptor, Science, 248, pp. 739-742, (1990)

Warr TA, Rao LV, Rappaport SI., Human plasma extrinsic pathway inhibitor activity: II. Plasma levels in disseminated intravascular coagulation and hepatocellular disease, Blood, 74, pp. 994-998, (1989)

Dinarello CA, Gelfand JA, Wolff SM., Anticytokine strategies in the treatment of the systemic inflammatory response syndrome, JAMA, 269, pp. 1829-1835, (1993)

Tracey KJ, Fong Y., Hesse DG, Et al., Anti‐cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia, Nature, 330, pp. 662-664, (1987)

Van Zee KJ, Kohno T., Fischer E., Et al., Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor‐a in vitro and in vivo, Proc Natl Acad Sci USA, 89, pp. 4845-4849, (1992)

Arend WP., Interleukin 1 receptor antagonist. A new member of the interleukin 1 family, J Clin Invest, 88, pp. 1445-1451, (1991)

Gershenwald JE, Fong YM, Fahey TJ, Et al., Interleukin 1 receptor blockage attenuates the host inflammatory response, Proc Natl Acad Sci U S A, 87, pp. 4966-4970, (1990)

Fanslow WC, Sims JE, Sassenfeld H., Et al., Regulation of alloreactivity in vivo by a soluble form of the interleukin‐1 receptor, Science, 248, pp. 739-742, (1990)

Warr TA, Rao LV, Rappaport SI., Human plasma extrinsic pathway inhibitor activity: II. Plasma levels in disseminated intravascular coagulation and hepatocellular disease, Blood, 74, pp. 994-998, (1989)